$3.00
8.70% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US1511901050
Symbol
CELU

Celularity Inc - Ordinary Shares - Class A Stock price

$3.00
+1.14 61.29% 1M
-0.46 13.29% 6M
+0.53 21.26% YTD
+0.70 30.43% 1Y
-62.30 95.41% 3Y
-96.20 96.98% 5Y
-95.00 96.94% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.24 8.70%
ISIN
US1511901050
Symbol
CELU
Sector
Industry

Key metrics

Market capitalization $66.02m
Enterprise Value $132.91m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.11
P/S ratio (TTM) P/S ratio 1.55
P/B ratio (TTM) P/B ratio 2.37
Revenue growth (TTM) Revenue growth 182.02%
Revenue (TTM) Revenue $42.69m
EBIT (operating result TTM) EBIT $-44.70m
Free Cash Flow (TTM) Free Cash Flow $-21.39m
Cash position $470.00k
EPS (TTM) EPS $-5.82
Short interest 11.36%
Show more

Is Celularity Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Celularity Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Celularity Inc - Ordinary Shares - Class A:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Celularity Inc - Ordinary Shares - Class A:

Buy
100%

Financial data from Celularity Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
43 43
182% 182%
100%
- Direct Costs 26 26
4% 4%
60%
17 17
275% 275%
40%
- Selling and Administrative Expenses 53 53
3% 3%
124%
- Research and Development Expense - -
-
-
-36 -36
67% 67%
-84%
- Depreciation and Amortization 8.79 8.79
7% 7%
21%
EBIT (Operating Income) EBIT -45 -45
63% 63%
-105%
Net Profit -113 -113
36% 36%
-264%

In millions USD.

Don't miss a Thing! We will send you all news about Celularity Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Celularity Inc - Ordinary Shares - Class A Stock News

Neutral
GlobeNewsWire
6 days ago
FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that its strategic partner, Genting Berhad, has broken ground on Fontaine Vitale, a state-of-the-art stem cell and regenerative medicine facility in the Sanur Special Economic Zone located in Bali, Indonesia. Fontaine Vitale will offe...
Neutral
GlobeNewsWire
8 days ago
FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that the Nasdaq Listing Qualifications Hearings Panel (the “Hearings Panel”) has cancelled the previously scheduled hearing regarding Celularity's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), as the Company has cur...
Neutral
GlobeNewsWire
about one month ago
Celularity common stock and warrants will continue to trade on The Nasdaq Capital Market under the symbols “CELU” and “CELUW,” respectively Celularity common stock and warrants will continue to trade on The Nasdaq Capital Market under the symbols “CELU” and “CELUW,” respectively
More Celularity Inc - Ordinary Shares - Class A News

Company Profile

Celularity, Inc. a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The firms CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. The company is headquartered in Florham Park, NJ.

Head office United States
CEO Robert Gordon
Employees 120
Founded 2016
Website www.celularity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today